Pathogenic mutations cause highly significant alteration in kinase activity of LRRK2, including the most common mutation of PD, G2019S, which consistently induces 2 to 3-fold increases in kinase activity, resulting in neuronal toxicity [10]. The gene discussed is LRRK2; the disease is Parkinson disease.